
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
FAM118B CRISPR/Cas9 KO Plasmid (h) | sc-413182 | 20 µg | $397.00 |
FAM118B encodes a poorly characterized human protein that is predicted to participate in fundamental cellular homeostasis, with emerging evidence linking FAM118 family members to RNA-associated processes and nuclear organization. Basal expression of FAM118B across tissues suggests a role in maintaining core gene expression programs that intersect with cell-cycle progression, stress responses, and proteostasis networks. Altered expression patterns have been reported in multi-omic cancer datasets and other disease contexts, supporting its use as a candidate regulator in studies of tumor biology and cell fitness. Because its molecular function remains incompletely defined, FAM118B is well suited for hypothesis-driven interrogation using genetic perturbation to map downstream pathways and interaction partners.
FAM118B CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the FAM118B gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the FAM118B together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the FAM118B open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish FAM118B protein expression.
This CRISPR knockout system enables efficient generation of FAM118B-deficient cell models for investigation of FAM118B signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.